癌症患者-话题@MedSci

#癌症患者#

374篇内容 | 6622人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1289741, encodeId=969f1289e41ca, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=ESMO Open：在抗肿瘤治疗的癌症患者中，BNT162b2冠状病毒2019信使RNA疫苗接种后体液免疫应答降低, objectType=article, longId=218280, objectId=a9bf2182807d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9bf2182807d, replyNumber=0, likeNumber=101, createdTime=2021-10-10, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9bf2182807d, moduleTitle=ESMO Open：在抗肿瘤治疗的癌症患者中，BNT162b2冠状病毒2019信使RNA疫苗接种后体液免疫应答降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9bf2182807d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289739, encodeId=b2d71289e397d, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=J Immunother Cancer：接受免疫检查点抑制剂治疗的癌症患者患肺结核的风险比普通人高 8 倍！, objectType=article, longId=217341, objectId=3de021e34127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3de021e34127, replyNumber=0, likeNumber=80, createdTime=2021-09-21, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3de021e34127, moduleTitle=J Immunother Cancer：接受免疫检查点抑制剂治疗的癌症患者患肺结核的风险比普通人高 8 倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3de021e34127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289738, encodeId=97191289e384f, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=JNCI：免疫检查点抑制剂治疗的癌症患者的生活质量, objectType=article, longId=217178, objectId=1cec21e17813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cec21e17813, replyNumber=0, likeNumber=88, createdTime=2021-09-17, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cec21e17813, moduleTitle=JNCI：免疫检查点抑制剂治疗的癌症患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cec21e17813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289737, encodeId=d6341289e37da, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=JNCI：癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性, objectType=article, longId=216495, objectId=7e9f21649542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9f21649542, replyNumber=0, likeNumber=71, createdTime=2021-09-01, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9f21649542, moduleTitle=JNCI：癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9f21649542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289736, encodeId=c0761289e3680, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Eur J Cancer：发生与免疫治疗相关的结节样肉芽肿的癌症患者的预后, objectType=article, longId=216347, objectId=495721634eac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495721634eac, replyNumber=0, likeNumber=79, createdTime=2021-08-28, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495721634eac, moduleTitle=Eur J Cancer：发生与免疫治疗相关的结节样肉芽肿的癌症患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=495721634eac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289735, encodeId=63bd1289e35d2, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Cancer Cell：序贯组合疗法可以使治疗对侵袭性癌症患者更有效！, objectType=article, longId=216071, objectId=f5632160e196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5632160e196, replyNumber=0, likeNumber=104, createdTime=2021-08-22, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5632160e196, moduleTitle=Cancer Cell：序贯组合疗法可以使治疗对侵袭性癌症患者更有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5632160e196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289734, encodeId=0ec11289e3473, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=PLOS Med：癌症可能也“伤心”？来看看癌症患者心脏风险分层, objectType=article, longId=215980, objectId=cb01215980b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb01215980b1, replyNumber=0, likeNumber=95, createdTime=2021-08-20, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb01215980b1, moduleTitle=PLOS Med：癌症可能也“伤心”？来看看癌症患者心脏风险分层, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb01215980b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289733, encodeId=11241289e33d1, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Brit J Cancer：癌症患者COVID-19死亡风险, objectType=article, longId=215933, objectId=6f99215933a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f99215933a7, replyNumber=0, likeNumber=71, createdTime=2021-08-19, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f99215933a7, moduleTitle=Brit J Cancer：癌症患者COVID-19死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f99215933a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289732, encodeId=56531289e32d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=J Urol：男性癌症患者的射精障碍：患病率的系统回顾和元分析 , objectType=article, longId=215521, objectId=ef2321552135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef2321552135, replyNumber=0, likeNumber=91, createdTime=2021-08-11, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef2321552135, moduleTitle=J Urol：男性癌症患者的射精障碍：患病率的系统回顾和元分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef2321552135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289731, encodeId=e0591289e31fc, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Leukemia：供体来源的NK细胞可降低异基因造血干细胞移植后癌症患者的复发率, objectType=article, longId=215446, objectId=0330215446c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0330215446c7, replyNumber=0, likeNumber=74, createdTime=2021-08-09, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0330215446c7, moduleTitle=Leukemia：供体来源的NK细胞可降低异基因造血干细胞移植后癌症患者的复发率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0330215446c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289729, encodeId=4dfc1289e29fb, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=不容忽视！有疲劳症的癌症患者生存结果更差, objectType=article, longId=215082, objectId=9d9f215082cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d9f215082cd, replyNumber=0, likeNumber=61, createdTime=2021-08-01, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d9f215082cd, moduleTitle=不容忽视！有疲劳症的癌症患者生存结果更差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d9f215082cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289730, encodeId=ad371289e3062, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布, objectType=article, longId=215078, objectId=585a2150e865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=585a2150e865, replyNumber=0, likeNumber=59, createdTime=2021-08-01, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=585a2150e865, moduleTitle=Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=585a2150e865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289728, encodeId=fa361289e28ee, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Gut：癌症患者要当心，免疫疗法效果不佳可能是幽门螺杆菌在作怪！, objectType=article, longId=214201, objectId=917b21420197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=917b21420197, replyNumber=0, likeNumber=72, createdTime=2021-07-15, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=917b21420197, moduleTitle=Gut：癌症患者要当心，免疫疗法效果不佳可能是幽门螺杆菌在作怪！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=917b21420197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289727, encodeId=50121289e2787, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Lancet Oncology：癌症患者的希望之光，万能靶向药再出手，可降低78%疾病进展与死亡危险！, objectType=article, longId=214170, objectId=8d5e2141e01b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d5e2141e01b, replyNumber=0, likeNumber=83, createdTime=2021-07-15, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d5e2141e01b, moduleTitle=Lancet Oncology：癌症患者的希望之光，万能靶向药再出手，可降低78%疾病进展与死亡危险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d5e2141e01b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289726, encodeId=91d01289e265c, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle= Nat Metab：线粒体DNA突变，竟能降低癌症患者死亡风险, objectType=article, longId=214107, objectId=911a21410e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=911a21410e3d, replyNumber=0, likeNumber=71, createdTime=2021-07-14, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=911a21410e3d, moduleTitle= Nat Metab：线粒体DNA突变，竟能降低癌症患者死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=911a21410e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289725, encodeId=052a1289e2527, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=阿司匹林或将癌症患者的死亡风险降低 20%, objectType=article, longId=213771, objectId=9094213e71dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9094213e71dc, replyNumber=0, likeNumber=76, createdTime=2021-07-07, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9094213e71dc, moduleTitle=阿司匹林或将癌症患者的死亡风险降低 20%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9094213e71dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289724, encodeId=c5b31289e249a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Ann Neurol:康奈尔大学新发现：癌症患者易患中风，或因血液高凝状态, objectType=article, longId=213763, objectId=f16a213e6326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f16a213e6326, replyNumber=0, likeNumber=51, createdTime=2021-07-06, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f16a213e6326, moduleTitle=Ann Neurol:康奈尔大学新发现：癌症患者易患中风，或因血液高凝状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f16a213e6326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289723, encodeId=911d1289e233d, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Nat Commun：肿瘤浸润性T细胞的T细胞受体库可预测癌症患者的预后, objectType=article, longId=213759, objectId=0010213e5918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0010213e5918, replyNumber=0, likeNumber=89, createdTime=2021-07-06, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0010213e5918, moduleTitle=Nat Commun：肿瘤浸润性T细胞的T细胞受体库可预测癌症患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0010213e5918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289722, encodeId=743c1289e2285, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Ecancermedicalscience :阿司匹林可将癌症患者的死亡风险降低 20%, objectType=article, longId=213694, objectId=1f6f21369412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f6f21369412, replyNumber=0, likeNumber=84, createdTime=2021-07-05, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f6f21369412, moduleTitle=Ecancermedicalscience :阿司匹林可将癌症患者的死亡风险降低 20%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f6f21369412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289721, encodeId=81c71289e2149, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, objectTitle=Cancer Cell：94% 的癌症患者对 COVID-19 疫苗反应良好, objectType=article, longId=213666, objectId=98df21366607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98df21366607, replyNumber=0, likeNumber=78, createdTime=2021-07-04, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98df21366607, moduleTitle=Cancer Cell：94% 的癌症患者对 COVID-19 疫苗反应良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98df21366607)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

癌症患者

2020-05-29

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

ESMO Open：在抗肿瘤治疗的癌症患者中，BNT162b2冠状病毒2019信使RNA疫苗接种后体液免疫应答降低

2021-10-10

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

J Immunother Cancer：接受免疫检查点抑制剂治疗的癌症患者患肺结核的风险比普通人高 8 倍！

2021-09-21

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

JNCI：免疫检查点抑制剂治疗的癌症患者的生活质量

2021-09-17

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

JNCI：癌症患者接种新冠疫苗 BNT162b2的免疫原性和安全性

2021-09-01

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Eur J Cancer：发生与免疫治疗相关的结节样肉芽肿的癌症患者的预后

2021-08-28

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Cancer Cell：序贯组合疗法可以使治疗对侵袭性癌症患者更有效！

2021-08-22

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

PLOS Med：癌症可能也“伤心”？来看看癌症患者心脏风险分层

2021-08-20

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Brit J Cancer：癌症患者COVID-19死亡风险

2021-08-19

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

J Urol：男性癌症患者的射精障碍：患病率的系统回顾和元分析

2021-08-11

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Leukemia：供体来源的NK细胞可降低异基因造血干细胞移植后癌症患者的复发率

2021-08-09

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

不容忽视！有疲劳症的癌症患者生存结果更差

2021-08-01

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布

2021-08-01

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Gut：癌症患者要当心，免疫疗法效果不佳可能是幽门螺杆菌在作怪！

2021-07-15

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Lancet Oncology：癌症患者的希望之光，万能靶向药再出手，可降低78%疾病进展与死亡危险！

2021-07-15

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Nat Metab：线粒体DNA突变，竟能降低癌症患者死亡风险

2021-07-14

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

阿司匹林或将癌症患者的死亡风险降低 20%

2021-07-07

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Ann Neurol:康奈尔大学新发现：癌症患者易患中风，或因血液高凝状态

2021-07-06

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Nat Commun：肿瘤浸润性T细胞的T细胞受体库可预测癌症患者的预后

2021-07-06

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Ecancermedicalscience :阿司匹林可将癌症患者的死亡风险降低 20%

2021-07-05

zgwhgch (审核中...)

前往app查看评论内容

#癌症患者#

Cancer Cell：94% 的癌症患者对 COVID-19 疫苗反应良好

2021-07-04

科室
- - 订阅+
  - 更多科室
工具
服务